Ποια είναι η τιμή για Chembio Diagnostics, Inc. (CEMI)

Η τιμή για Chembio Diagnostics, Inc. (CEMI) είναι $0.455

Ποια είναι η κεφαλαιοποίηση αγοράς για Chembio Diagnostics, Inc. (CEMI)

Η κεφαλαιοποίηση αγοράς για Chembio Diagnostics, Inc. (CEMI) είναι $7.70M

Chembio Diagnostics, Inc. (CEMI) Τιμή και Κεφαλαιοποίηση Αγοράς

Chembio Diagnostics, Inc., along with its subsidiaries, specializes in creating, producing, and bringing to market point-of-care (POC) diagnostic tests used for identifying and diagnosing various diseases. Their current product offerings include tests for critical conditions like COVID-19, HIV/Syphilis, and the Zika virus. Beyond these, the company is dedicated to advancing diagnostics for a wide array of other infectious diseases, such as malaria, dengue, chikungunya, Chagas disease, Ebola, leishmaniasis, Lassa fever, Marburg virus, leptospirosis, rickettsia, and Burkholderia infections. These diagnostic tools are sold under well-known brand names including STAT-PAK, SURE CHECK, STAT VIEW, and DPP. Chembio distributes its products directly and through various partners to a diverse global customer base. This clientele includes medical laboratories, hospitals, government and public health agencies, non-governmental organizations (NGOs), medical professionals, and retail outlets across the United States and worldwide. The company engages in strategic partnerships with prominent organizations such as the Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics. Additionally, Chembio collaborates with several key U.S. government entities, including the Centers for Disease Control and Prevention (CDC), the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture (USDA). Founded in 1985, Chembio Diagnostics, Inc. has its headquarters located in Hauppauge, New York.

Η τιμή για CEMI	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$322,126 $7.70M	NVDA	$5.452T	+70,796,852.37%
$265,295 $7.70M	AAPL	$4.490T	+58,306,476.69%
$245,938 $7.70M	GOOG	$4.162T	+54,052,152.53%
$217,218 $7.70M	MSFT	$3.676T	+47,740,207.23%
$167,392 $7.70M	AMZN	$2.833T	+36,789,270.85%

Η τιμή για CEMI

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$322,126 $7.70M